Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction.

In the present paper, we examined the effects of a natural cyclopeptide RA-V on human breast cancer cells and the underlying mechanisms. RA-V significantly inhibited the growth of human breast cancer MCF-7, MDA-MB-231 cells and murine breast cancer 4T1 cells. In addition, RA-V triggered mitochondrial apoptotic pathway which was indicated by the loss of mitochondrial membrane potential, the release of cytochrome c, and the activation of caspase cascade. Further study showed that RA-V dramatically inhibited phosphorylation of AKT and 3-phosphoinositide dependent protein kinase 1 (PDK1) in MCF-7 cells. Moreover, RA-V disrupted the interaction between PDK1 and AKT in MCF-7 cells. Furthermore, RA-V-induced apoptosis could be enhanced by phosphatidylinositol 3-kinase inhibitor or attenuated by over-expression of AKT in all the three kinds of breast cancer cells. Taken together, this study shows that RA-V, which can induce mitochondria-mediated apoptosis, exerts strong anti-tumor activity against human breast cancer. The underlying anti-cancer mechanism of RA-V is related to the blockage of the interaction between PDK1 and AKT.

[1]  R. Weissleder,et al.  A stabilized demethoxyviridin derivative inhibits PI3 kinase. , 2009, Bioorganic & medicinal chemistry letters.

[2]  Jun-Jie Liu,et al.  Targeting apoptotic and autophagic pathways for cancer therapeutics. , 2011, Cancer letters.

[3]  A. Sánchez-Medina,et al.  The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. , 2011, Toxicology and applied pharmacology.

[4]  Anutosh Chakraborty,et al.  Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain , 2010, Cell.

[5]  Hua Yu,et al.  Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways , 2010, Molecular Cancer Research.

[6]  A. Goldhirsch,et al.  Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Martinou,et al.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. , 2011, Developmental cell.

[8]  Jia Li,et al.  Rubiyunnanins C-H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation. , 2010, Bioorganic & medicinal chemistry.

[9]  Qiang Xu,et al.  Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease. , 2010, Biochemical pharmacology.

[10]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[11]  P. Xie,et al.  Role of Extracellular Matrix Renal Tubulo-interstitial Nephritis Antigen (TINag) in Cell Survival Utilizing Integrin αvβ3/Focal Adhesion Kinase (FAK)/Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B-Serine/Threonine Kinase (AKT) Signaling Pathway* , 2011, The Journal of Biological Chemistry.

[12]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[13]  Inna N Lavrik,et al.  Caspases: pharmacological manipulation of cell death. , 2005, The Journal of clinical investigation.

[14]  Hyunseung Lee,et al.  HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. , 2012, Cancer letters.

[15]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[16]  H. Itokawa,et al.  Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix. , 1984, Chemical & pharmaceutical bulletin.

[17]  R. Tuma.  Three molecularly targeted drugs tested in kidney cancer clinical trials. , 2004, Journal of the National Cancer Institute.

[18]  M. Laguerre,et al.  Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition , 2009, PLoS biology.

[19]  J. McCubrey,et al.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.

[20]  Qiang Xu,et al.  Targeting Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase 2 by Curcumin Induces ER Stress-Associated Apoptosis for Treating Human Liposarcoma , 2011, Molecular Cancer Therapeutics.

[21]  Qiang Xu,et al.  Phosphatase of Regenerating Liver-3 Localizes to Cyto-Membrane and Is Required for B16F1 Melanoma Cell Metastasis In Vitro and In Vivo , 2009, PloS one.

[22]  V. Rasheva,et al.  Cellular responses to endoplasmic reticulum stress and apoptosis , 2009, Apoptosis.

[23]  Qiang Xu,et al.  Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf/ERK cascade and Akt signaling pathway. , 2011, Toxicology and applied pharmacology.

[24]  ScienceDirect,et al.  Toxicology and Applied Pharmacology , 1959, Nature.

[25]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[26]  Giorgio Colombo,et al.  Structure-Activity Relationships of Linear and Cyclic Peptides Containing the NGR Tumor-homing Motif* , 2002, The Journal of Biological Chemistry.

[27]  M. Oshimura,et al.  PI3K-Akt pathway: Its functions and alterations in human cancer , 2004, Apoptosis.

[28]  N. Tan,et al.  Plant cyclopeptides. , 2006, Chemical reviews.

[29]  T. Kudo,et al.  Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death , 2004, The Journal of cell biology.

[30]  Passeig Vall d'Hebron.  Targeted therapies in breast cancer: Where are we now? , 2008 .

[31]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[32]  M. Kuwano,et al.  Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. , 2004, Molecular cancer therapeutics.

[33]  S. Fulda,et al.  Targeting apoptosis pathways in cancer therapy. , 2004, Current cancer drug targets.

[34]  J. Ko,et al.  Lipocalin 2, a new GADD153 target gene, as an apoptosis inducer of endoplasmic reticulum stress in lung cancer cells. , 2012, Toxicology and applied pharmacology.

[35]  A. Wardley,et al.  Effective oral chemotherapy for breast cancer: pillars of strength. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  J. Vederas,et al.  Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.

[37]  K. Fung,et al.  Cyclopeptide RA‐V inhibits angiogenesis by down‐regulating ERK1/2 phosphorylation in HUVEC and HMEC‐1 endothelial cells , 2011, British journal of pharmacology.

[38]  C. Sugimoto,et al.  PI3K/Akt and apoptosis: size matters , 2003, Oncogene.

[39]  S. Hanks,et al.  Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.

[40]  J. Hong,et al.  Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. , 2012, Toxicology and applied pharmacology.

[41]  Yu Qin,et al.  Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice. , 2009, Biochemical pharmacology.